Literature DB >> 26722298

Predictive role of preoperative hydronephrosis on poor pathological outcomes and prognosis in upper tract urothelial carcinoma patients: Experience from a nationwide high-volume center in China.

Zheng Zhang1, Dong Fang1, Xiaopeng Chen1, Xuesong Li1, Gengyan Xiong1, Lei Zhang1, Qun He1, Liqun Zhou1.   

Abstract

To validate the predictive value of preoperative hydronephrosis (HN) with regard to clinicopathological outcome and prognosis in a large cohort of upper tract urothelial carcinoma (UTUC) patients, a retrospective analysis was conducted using the clinicopathological data of 520 consecutive patients treated between 2000 and 2010 at a nationwide high-volume center in China. Preoperative computed tomography or magnetic resonance imaging scans were evaluated for the presence of ipsilateral HN, and the associations between HN and pathological outcomes, patient survival and urinary tract recurrences were assessed. Ipsilateral HN was present in 271 patients (52.1%). Preoperative HN was associated with advanced age (P=0.007), sessile tumor architecture (P<0.001), ureteral location (P<0.001), higher tumor stage (P<0.001) and higher histological grade (P=0.002). Univariate and multivariate analyses revealed that poorer cancer-specific survival (CSS) and overall survival (OS) times were correlated with preoperative HN (P=0.004 and P=0.009, respectively). The 5-year CSS and OS rates for patients with HN were 86.9 and 86.2%, respectively, compared to 93.3 and 91.9% for patients without HN. For patients with muscle-invasive disease, HN remained a risk factor for poor CSS and OS (P=0.009 and P=0.012, respectively). No association was identified between HN and bladder recurrence (P=0.552) or the development of contralateral upper tract carcinoma (P=0.164). The findings indicated that preoperative HN is prevalent in UTUC. The presence of preoperative HN predicted poorer pathological outcomes and was a significant risk factor affecting survival. The evaluation of HN may be informative for decisions concerning surgical options, and the presence of HN should raise the possibility of employing an aggressive treatment approach.

Entities:  

Keywords:  pathological outcome; preoperative hydronephrosis; prognosis; radical nephroureterectomy; upper tract urothelial carcinoma

Year:  2015        PMID: 26722298      PMCID: PMC4665826          DOI: 10.3892/ol.2015.3653

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  40 in total

1.  Stage-specific impact of tumor location on oncologic outcomes in patients with upper and lower tract urothelial carcinoma following radical surgery.

Authors:  Michael Rink; Behfar Ehdaie; Eugene K Cha; David A Green; Pierre I Karakiewicz; Marko Babjuk; Vitaly Margulis; Jay D Raman; Robert S Svatek; Harun Fajkovic; Richard K Lee; Giacomo Novara; Jens Hansen; Siamak Daneshmand; Yair Lotan; Wassim Kassouf; Hans-Martin Fritsche; Armin Pycha; Margit Fisch; Douglas S Scherr; Shahrokh F Shariat
Journal:  Eur Urol       Date:  2012-02-15       Impact factor: 20.096

2.  Unusual clinical presentation of upper urothelial carcinoma in Taiwan.

Authors:  Y H Chou; C H Huang
Journal:  Cancer       Date:  1999-03-15       Impact factor: 6.860

3.  European guidelines on upper tract urothelial carcinomas: 2013 update.

Authors:  Morgan Rouprêt; Marko Babjuk; Eva Compérat; Richard Zigeuner; Richard Sylvester; Max Burger; Nigel Cowan; Andreas Böhle; Bas W G Van Rhijn; Eero Kaasinen; Joan Palou; Shahrokh F Shariat
Journal:  Eur Urol       Date:  2013-03-19       Impact factor: 20.096

Review 4.  The role of chemotherapy in the treatment of urothelial cell carcinoma of the upper urinary tract (UUT-UCC).

Authors:  François Audenet; David R Yates; Olivier Cussenot; Morgan Rouprêt
Journal:  Urol Oncol       Date:  2010-09-29       Impact factor: 3.498

5.  Multi-institutional validation of the ability of preoperative hydronephrosis to predict advanced pathologic tumor stage in upper-tract urothelial carcinoma.

Authors:  Jamie C Messer; John D Terrell; Michael P Herman; Casey K Ng; Douglas S Scherr; Benjamin Scoll; Stephen A Boorjian; Robert G Uzzo; Mark Wille; Scott E Eggener; Steven M Lucas; Yair Lotan; Shahrokh F Shariat; Jay D Raman
Journal:  Urol Oncol       Date:  2011-09-09       Impact factor: 3.498

6.  Renal function and oncologic outcomes of parenchymal sparing ureteral resection versus radical nephroureterectomy for upper tract urothelial carcinoma.

Authors:  Jonathan L Silberstein; Nicholas E Power; Caroline Savage; Tatum V Tarin; Ricardo L Favaretto; Daniel Su; Matthew G Kaag; Harry W Herr; Guido Dalbagni
Journal:  J Urol       Date:  2011-12-15       Impact factor: 7.450

7.  Influence of preoperative hydronephrosis on the outcome of urothelial carcinoma of the upper urinary tract after nephroureterectomy: the results from a multi-institutional French cohort.

Authors:  G Bozzini; L Nison; P Colin; A Ouzzane; D R Yates; F Audenet; G Pignot; A Arvin-Berod; O Merigot; L Guy; J Irani; F Saint; S Gardic; P Gres; F Rozet; Y Neuzillet; A Ruffion; M Roupret
Journal:  World J Urol       Date:  2012-10-11       Impact factor: 4.226

8.  Preoperative hydronephrosis and diabetes mellitus predict poor prognosis in upper urinary tract urothelial carcinoma.

Authors:  Insang Hwang; Seung Il Jung; Deok-Hyun Nam; Eu Chang Hwang; Taek Won Kang; Dong Deuk Kwon; Soo Bang Ryu
Journal:  Can Urol Assoc J       Date:  2013 Mar-Apr       Impact factor: 1.862

9.  Does the presence of hydronephrosis on preoperative axial CT imaging predict worse outcomes for patients undergoing nephroureterectomy for upper-tract urothelial carcinoma?

Authors:  Casey K Ng; Shahrokh F Shariat; Steven M Lucas; Aditya Bagrodia; Yair Lotan; Douglas S Scherr; Jay D Raman
Journal:  Urol Oncol       Date:  2008-12-30       Impact factor: 3.498

10.  Increased upper and lower tract urothelial carcinoma in patients with end-stage renal disease: a nationwide cohort study in Taiwan during 1997-2008.

Authors:  Shuo-Meng Wang; Ming-Nan Lai; Pau-Chung Chen; Yeong-Shiau Pu; Ming-Kuen Lai; Jing-Shiang Hwang; Jung-Der Wang
Journal:  Biomed Res Int       Date:  2014-06-16       Impact factor: 3.411

View more
  5 in total

1.  Preoperative hydronephrosis as a predictor of postnephroureterectomy survival in patients with upper tract urothelial carcinoma: a two-center study in Japan.

Authors:  Tomohiro Fukui; Toru Kanno; Go Kobori; Seiji Moroi; Hitoshi Yamada
Journal:  Int J Clin Oncol       Date:  2019-09-03       Impact factor: 3.402

2.  Comparisons of prognosis between urothelial carcinoma of the upper urinary tract and bladder with pT3-4 cancer.

Authors:  Xiaohong Su; Qi Tang; Dong Fang; Gengyan Xiong; Nirmish Singla; Qun He; Lei Zhang; Pei Liu; Yu Fan; Han Hao; Xuesong Li; Liqun Zhou
Journal:  Int J Clin Exp Med       Date:  2016-09-30

3.  Validation of the Pretreatment Neutrophil-to-Lymphocyte Ratio as a Prognostic Factor in a Large Cohort of Chinese Patients with Upper Tract Urothelial Carcinoma.

Authors:  Zhen-Peng Cao; Bao Guan; Guang-Zhi Zhao; Dong Fang; Geng-Yan Xiong; Xue-Song Li; Li-Qun Zhou
Journal:  Chin Med J (Engl)       Date:  2017-09-05       Impact factor: 2.628

4.  Intravesical recurrence factors and outcome after radical nephroureterectomy for upper tract urothelial carcinoma: Multivariate analysis with propensity score matching.

Authors:  Hang Zhao; Binbin Jiao; Kunpeng Liu; Zhenkai Luo; Zhenshan Ding; Shicong Lai; Jian Ren; Guan Zhang
Journal:  Front Oncol       Date:  2022-08-18       Impact factor: 5.738

5.  Clinical and prognostic value of preoperative hydronephrosis in upper tract urothelial carcinoma: a systematic review and meta-analysis.

Authors:  Yuejun Tian; Yuwen Gong; Yangyang Pang; Zhiping Wang; Mei Hong
Journal:  PeerJ       Date:  2016-06-21       Impact factor: 2.984

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.